Evaluating Angiogenic Potential of Small Molecules Using Genetic Network Approaches

Area of Science:

• Biomedical Engineering
• Molecular Biology
• Pharmacology

Background:

• Microvascular network growth is crucial for treating ischemic diseases and tissue engineering.
• Current angiogenesis therapies often overlook complex signaling pathway interactions.
• Developing novel small molecules to precisely control angiogenesis is a significant challenge.

Purpose of the Study:

• To synthesize and evaluate novel phthalimide neovascularization factor (PNF) analogs.
• To investigate the effects of structural modifications on angiogenic signaling.
• To elucidate the underlying molecular mechanisms of PNF-mediated neovascularization.

Main Methods:

• Systematic chemical modifications of the PNF1 scaffold to create analogs (SC-3-143, SC-3-263, SC-3-13).
• Pathway compendium analysis of PNF-analog-stimulated microvascular endothelial cells.
• Partial Least Squares Regression (PLSR) modeling to predict endothelial cell proliferation.

Main Results:

• Structural variations influenced angiogenic signaling pathways.
• Compendium analysis revealed PNF analogs modulate transcriptional networks.
• PLSR models successfully predicted endothelial cell proliferation based on compendium variables.
• Proposed mechanisms involve TGF-β and NR3C1 network activation, potentially suppressing VEGF pathways.

Conclusions:

• Novel PNF analogs offer potential for therapeutic angiogenesis.
• Understanding structure-activity relationships is key to optimizing neovascularization factors.
• The study provides insights into signaling pathways regulating microvascular growth, including TGF-β and NR3C1 networks.